AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $59.6M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$59.6M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 5 added, 8 cutMore cutting
Key stats
Fundamentals Oct 1- Open
- $223.66
- 52-wk high
- $258.30
- High
- $226.49
- 52-wk low
- $149.72
- Low
- $222.07
- Prev close
- $223.91
- Mkt cap
- $51.52B
- P/E
- 30.9x
- Volume
- 1.94M
- Fwd P/E
- 17.7x
- Beta
- 0.52
- Div yield
- 0.91%
- P/S
- 0.2x
- P/B
- 16.1x
- Profit margin
- +0.7%
- Op margin
- +1.3%
- ROE
- +0.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CAH filings
Are insiders buying or selling Cardinal Health Inc (CAH) stock?
Net selling: insiders sold $59.6M and bought $0 of CAH stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. The largest was Hollar, Jason M. (Chief Executive Officer), who sold $29.4M. The latest filing was on Aug 20, 2026.
Which members of Congress have traded CAH recently?
None. No member of Congress disclosed a CAH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CAH smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Sells/Trims (3)
- CI
Citadel
$446.8M
trimmed
- QR
Qube Research
$188.1M
trimmed
- TS
Two Sigma
$92.6M
trimmed
What insiders are doing
What Congress is doing
Buys (1)
How top traders are positioned
No tracked top-trader positions in CAH right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 20.2% above what analysts expected.
Earnings per share
$2.42 expected
Revenue
$65.11B expected
Reports Oct 29, 2026, in 28 days
Estimates as of Sep 30, 2026
EPS expected
$2.88 to $3.06
Revenue expected
10 analysts
Last 30 days
Analysts raising estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $64.01B | $65.44B | $60.94B | $63.86B |
| Cost of what it sold | $61.69B | $63.23B | $58.44B | $61.11B |
| Gross profit | $2.32B | $2.21B | $2.50B | $2.75B |
| What it spent | ||||
| Sales and admin | $1.46B | $1.50B | $1.54B | $1.63B |
| Other operating costs | $190.0M | — | $447.0M | $392.0M |
| Total operating expenses | $1.65B | $1.50B | $1.99B | $2.02B |
| What was left | ||||
| Operating profit | $668.0M | $707.0M | $509.0M | $729.0M |
| Interest on debt | $80.0M | $88.0M | $101.0M | $79.0M |
| Profit before tax | $598.0M | $630.0M | $392.0M | $554.0M |
| Tax | $144.0M | $159.0M | $12.0M | $154.0M |
| Net profit | $450.0M | $471.0M | $399.0M | $394.0M |
| EBITDA | $911.0M | $707.0M | $741.0M | $1.12B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Why Is Cardinal Health and McKesson Stock Trading Higher Today - CVS Health (NYSE:CVS), McKesson (NYSE:MC
BullishOct 1Cardinal Health Extends CVS Health Pharmaceutical Distribution Agreement Through 2032
Leans bullishOct 1Cardinal Health to report Q1 fiscal 2027 results on Nov 5 before NYSE opens
Leans bullishOct 1Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
NeutralOct 1Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
BullishOct 1Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
BullishOct 1Cardinal Health to Announce First-Quarter Results for Fiscal Year 2027 on November 5
NeutralOct 1How Investors May Respond To McKesson (MCK) Raised 2027 EPS Guidance
NeutralOct 1
Macro
10 macro signals shaping CAH right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results